GNH USA

Europe — EMA

Mutaflor Mite (Escherichia Coli Strain Nissle 1917)

GNH USA supplies Mutaflor Mite (Escherichia coli Nissle 1917), a probiotic for microbiota balance and gastrointestinal health. Request a quote for supply.

Escherichia Coli Strain Nissle 1917

Request sourcing

1
Pack/s

What is Escherichia Coli Strain Nissle 1917?

Escherichia coli Nissle 1917, the active ingredient in Mutaflor Mite, is a probiotic presented as an oral formulation for oral use. It is employed to support gastrointestinal health by helping to maintain a balanced intestinal microbiota in adults and children.

GNH USA supplies Mutaflor Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide across multiple regions. The company ensures quality control, regulatory compliance and reliable logistics through global distribution and timely efficient delivery.

What is Escherichia Coli Strain Nissle 1917 used for?

Mutaflor Mite, a probiotic containing Escherichia coli Nissle 1917, is used in gastrointestinal conditions where modulation of the intestinal microbiota is beneficial.

- Ulcerative colitis: helps maintain remission and reduce flare‑ups. - Pouchitis: lowers recurrence rates after ileal‑pouch‑anal anastomosis. - Antibiotic‑associated diarrhea: restores microbial balance to alleviate symptoms.

What are the side effects of Escherichia Coli Strain Nissle 1917?

Adverse reactions reported with Mutaflor Mite are generally mild and related to the gastrointestinal tract.

Common Side Effects: - Abdominal discomfort: mild pain or cramping. - Flatulence: increased intestinal gas. - Bloating: sensation of fullness. - Nausea: occasional feeling of queasiness. - Diarrhea: loose stools. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Bacteremia or sepsis: systemic infection, primarily in severely immunocompromised patients. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Persistent high fever: may indicate infection. - Severe abdominal pain: unexplained intense pain. - Unexplained weight loss: significant loss without other cause.

What precautions apply to Escherichia Coli Strain Nissle 1917?

When considering Mutaflor Mite, several safety aspects should be reviewed.

- Immunocompromised patients: assess risk before use. - Known hypersensitivity: avoid if allergic to E. coli strains. - Concurrent antibiotics: consider timing to preserve probiotic viability. - Pediatric use: follow prescriber guidance for children. - Pregnancy and lactation: consult healthcare professional due to limited data. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

What does Escherichia Coli Strain Nissle 1917 interact with?

Mutaflor Mite may interact with other medicines or substances.

Major Interactions (Avoid): - Systemic antibiotics: may eradicate the probiotic strain, reducing efficacy. - Immunosuppressive therapy: increased risk of infection with live bacteria.

Moderate Interactions (Monitor Closely): - Antacids or acid‑reducing agents: may alter gastric pH and affect bacterial survival. - Other probiotic products: potential competition or additive effects. - Antifungal agents: may impact gut flora balance indirectly.

Frequently asked questions

What is Mutaflor Mite used for?+
Mutaflor Mite is a probiotic containing Escherichia coli Nissle 1917 that is used to support gastrointestinal health, particularly for maintaining remission in ulcerative colitis, preventing pouchitis recurrence, and managing antibiotic‑associated diarrhea by restoring a balanced gut microbiota.
How does Escherichia coli Nissle 1917 work?+
The strain colonises the intestinal lining, competes with harmful bacteria for nutrients and adhesion sites, produces antimicrobial substances, and interacts with the host immune system to reduce inflammation and promote a stable, diverse microbial community.
What is the usual dose of Mutaflor Mite?+
The dosage of Mutaflor Mite is determined by the prescribing healthcare professional based on the individual’s condition, age, and clinical response. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.
Is Mutaflor Mite safe during pregnancy or breastfeeding?+
Safety data for Mutaflor Mite in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing it to pregnant or nursing women.
How do I order Mutaflor Mite from GNH USA?+
To order Mutaflor Mite, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mutaflor Mite compare with other probiotics?+
Mutaflor Mite contains a single, well‑studied strain (E. coli Nissle 1917) with documented efficacy in ulcerative colitis and pouchitis, whereas many other probiotics combine multiple strains with broader but less specific evidence. The choice depends on the clinical indication and physician preference.
How should Mutaflor Mite be stored?+
Mutaflor Mite should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product sealed until use helps maintain bacterial viability.
How is Mutaflor Mite administered?+
Mutaflor Mite is taken orally, usually as a capsule or sachet, according to the prescriber’s directions. It may be swallowed with water and can be taken with or without food, depending on the specific recommendation.
What are the most serious risks to watch for?+
The most serious risks include systemic infection such as bacteremia or sepsis, especially in severely immunocompromised individuals, and severe allergic reactions that may present as rash, swelling or anaphylaxis. Any signs of infection or allergic response should prompt immediate medical attention.
Who should not use Mutaflor Mite?+
Mutaflor Mite should be avoided in patients with known hypersensitivity to E. coli strains, in those who are severely immunocompromised without medical supervision, and in individuals where the prescriber determines the risks outweigh the benefits.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Escherichia Coli Strain Nissle 1917
Route
Oral Use
Manufacturer
Ardeypharm Gmbh
Origin
EU

Related products

Eubioflor

Eubioflor

Escherichia Coli Strain Nissle 1917

Ardeypharm Gmbh
EU
Eubioflor Mite

Eubioflor Mite

Escherichia Coli Strain Nissle 1917

Ardeypharm Gmbh
EU
Mutaflor

Mutaflor

Escherichia Coli Strain Nissle 1917

Ardeypharm Gmbh
EU
Mutaflor

Mutaflor

Escherichia Coli Strain Nissle 1917

Ardeypharm Gmbh
EU